Centessa Pharmaceuticals Plc (0ACX)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 6.85M |
| Operating Income | -374.08M | -212.26M | -171.28M |
| Pre Tax Income | -380.96M | -216.95M | -176.14M |
| Net Income | -381.07M | -216.21M | -151.09M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -4.235 | -2.28 | -1.53 |
| EBIT | -374.08M | -209.92M | -176.71M |
| EBITDA | -374.05M | -212.13M | -170.47M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
